Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
mAB 2-17
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021
mAB 4-18
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021
mAB 5-24
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021
mAB 1-87
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021
mAB 1-68
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021
mAb 2-51
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021
7-bromo-5-chloro-8-hydroxyquinoline
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/11/2021
STE73-2E9
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/11/2021
RBD immunogen
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/11/2021
Emetine
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
ACE2-GpA-RBC
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
Pyronaridine
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
rMeV-preS
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/09/2021
rMVAs
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/09/2021
Aptamer-2
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
Aptamer-1
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
COVA1-16
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
mAb 2-36
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
mAb 2-7
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
mAb 2-15
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021